Fig. 3From: Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19Time course for syndecan-1 (SDC-1) between severe and critical COVID-19 patients. SDC-1 remained elevated until day14 of hospitalization from admission day. Daily values are represented as means (± sem; *P < 0.05)Back to article page